We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+9.72%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$16.2B
AUM Growth
+$1.16B
(+7.7%)
Cap. Flow
-$70.2M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
13.75%
Holding
668
New
158
Increased
115
Reduced
144
Closed
223
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$255M |
| 2 |
Broadcom
AVGO
|
+$180M |
| 3 |
AstraZeneca
AZN
|
+$147M |
| 4 |
Intuitive Surgical
ISRG
|
+$142M |
| 5 |
TE Connectivity
TEL
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$441M |
| 2 |
AerCap
AER
|
+$184M |
| 3 |
Western Digital
WDC
|
+$157M |
| 4 |
Akamai
AKAM
|
+$127M |
| 5 |
EPAM Systems
EPAM
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.67% |
| 2 | Consumer Discretionary | 14.19% |
| 3 | Industrials | 13.31% |
| 4 | Healthcare | 12.83% |
| 5 | Financials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
OneSpaWorld
OSW
$2.62B
| $1.32M | 0.01% |
+100,000
| New | +$1.35M |
|
402
Nautilus Biotechnolgy
NAUT
$110M
| $1.3M | 0.01% |
441,018
| – | – |
|
403
Visteon
VC
$2.8B
| $1.27M | 0.01% |
+10,793
| New | +$1.26M |
|
404
SentinelOne
S
$7.62B
| $1.24M | 0.01% |
+53,098
| New | +$1.39M |
|
405
CALL
Alvotech
ALVO
$1.28B
| $1.22M | 0.01% |
100,000
| – | – |
|
406
UiPath
PATH
$8.08B
| $1.19M | 0.01% |
+52,359
| New | +$1.23M |
|
407
Ingersoll Rand
IR
$33.6B
| $1.19M | 0.01% |
12,483
-3,965
| -24% | -$339K |
|
408
Wabtec
WAB
$49.7B
| $1.15M | 0.01% |
7,924
-9,399
| -54% | -$1.27M |
|
409
Fractyl Health
GUTS
$107M
| $1.11M | 0.01% |
+150,000
| New | +$1.26M |
|
410
Old Dominion Freight Line
ODFL
$44.1B
| $1.08M | 0.01% |
+4,920
| New | +$1.03M |
|
|
FNA
411
DELISTED
Paragon 28, Inc.
FNA
| $1.02M | 0.01% |
82,192
| – | – |
|
412
CALL
SELLAS Life Sciences
SLS
$2.17B
| $1.01M | 0.01% |
1,000,000
-275,000
| -22% | -$231K |
|
413
Nektar Therapeutics
NKTR
$2.53B
| $999K | 0.01% |
71,285
-163,333
| -70% | -$1.71M |
|
414
Webster Financial
WBS
$12.8B
| $959K | 0.01% |
18,880
-591,137
| -97% | -$28.9M |
|
415
CALL
Intelligent Bio Solutions
INBS
$4.69M
| $941K | 0.01% |
+22,291
| New | +$923K |
|
416
CALL
Village Farms International
VFF
$289M
| $918K | 0.01% |
740,000
| – | – |
|
417
Cognition Therapeutics
CGTX
$99.8M
| $910K | 0.01% |
+500,000
| New | +$1.03M |
|
418
GSK
GSK
$104B
| $892K | 0.01% |
+20,804
| New | +$858K |
|
|
419
Intelligent Bio Solutions
INBS
$4.69M
| $864K | 0.01% |
+20,620
| New | +$854K |
|
420
NewAmsterdam Pharma
NAMS
$3.34B
| $843K | 0.01% |
+35,641
| New | +$723K |
|
421
TransDigm Group
TDG
$67.6B
| $833K | 0.01% |
+676
| New | +$761K |
|
422
Trane Technologies
TT
$105B
| $814K | 0.01% |
+2,710
| New | +$736K |
|
423
Acuity Brands
AYI
$10.6B
| $792K | ﹤0.01% |
+2,946
| New | +$714K |
|
424
Cytek Biosciences
CTKB
$606M
| $671K | ﹤0.01% |
100,000
| – | – |
|
425
Caribou Biosciences
CRBU
$165M
| $643K | ﹤0.01% |
125,000
| – | – |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q1 2024 Portfolio in Review
As of Q1 2024, Alyeska Investment Group held 668 positions worth $16.2B, up 7.7% from $15.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Alyeska Investment Group's Q1 2024 filing shows 158 new, 115 increased, 144 reduced and 223 closed positions. Its largest new stake was Alphabet (Google) Class A: 1,783,151 shares worth $269M. The largest sale was Meta Platforms (Facebook), an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Alyeska Investment Group's largest Q1 2024 buy was Alphabet (Google) Class A: 1,783,151 shares worth $269M.
- Alyeska Investment Group added most to AstraZeneca in Q1 2024, an estimated $147M increase.
- Alyeska Investment Group's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $441M.
- Alyeska Investment Group fully exited Akamai in Q1 2024, selling an estimated $127M.
- Alyeska Investment Group's ten largest holdings make up 14% of its $16.2B portfolio in Q1 2024.
- Alyeska Investment Group opened 158 new positions and closed 223 in Q1 2024.
- Alyeska Investment Group's portfolio value rose 7.7% quarter-over-quarter to $16.2B.
Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.